Particular international locations consist of a "substantially related" capture-all clause in their drug legislation, including New Zealand and Australia. This features six-APB mainly because it is similar in chemical structure to the class A drug MDA, meaning 6-APB may very well be seen for a controlled material analogue in these jurisdictions.[19